Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process
1996

How Corticosteroids Work to Reduce Inflammation

Sample size: 9 publication Evidence: moderate

Author Information

Author(s): G. S. Madretsma, A. P. M. van Dijk, C. J. A. M. Tak, J. H. P. Wilson, F. J. Zijlstra

Primary Institution: Erasmus University Rotterdam

Hypothesis

The inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process.

Conclusion

Corticosteroids inhibit the production of inflammatory mediators through a glucocorticoid receptor-mediated process, but individual responses may vary.

Supporting Evidence

  • Corticosteroids decrease inflammation severity in many patients.
  • Approximately 10-40% of patients do not respond to corticosteroids.
  • Dexamethasone inhibited the production of TNF-a, IL-6, and PGE2 but not LTB4.
  • RU486 blocked the effect of dexamethasone, indicating receptor involvement.
  • Inter-individual variation in response to corticosteroids was observed.

Takeaway

Corticosteroids help reduce inflammation by blocking certain chemicals in the body, but not everyone responds the same way.

Methodology

Mononuclear cells were isolated from healthy volunteers and treated with dexamethasone and stimulants to measure the production of inflammatory mediators.

Limitations

The study only included healthy volunteers, which may not represent responses in patients with inflammatory diseases.

Participant Demographics

Nine healthy adults aged 22 to 37 years.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% confidence interval of 10-400nM for TNF-a, 15-1095 nM for IL-6, and 30-690 nM for PGE2.

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication